Analyst consensus rating
agilon health Analyst Rating: Buy
Direct answer
agilon health's consensus rating is Buy.
12 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $115.83.
Forecast evidence checked October 27, 2026.
Get free agilon health email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $90.65
- Average price target
- $115.83
- High price target
- $146.00
- Low price target
- $85.00
- Low target gap
- -6.2%
- Target upside
- +27.8%
- High target gap
- +61.1%
- Target range width
- 67.3%
- Consensus rating
- Buy
- Analysts
- 12
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for agilon health?
agilon health has a verified Buy consensus. The same dataset has an average price target of $115.83.
How far are agilon health's low and high targets from the recorded price?
The low target implies -6.2%, while the high target implies +61.1%.
How many analysts are included in agilon health's consensus?
The verified consensus includes 12 analysts.
How is agilon health's target upside or downside calculated?
The average target of $115.83 is divided by the recorded price of $90.65, then one is subtracted to produce +27.8%. This does not guarantee a future return.
When was agilon health's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.